Board approves Dividend
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its Meeting held today i.e. May 19, 2017, recommended a Final Dividend of Rs. 40/- (Rupees Forty Only) per equity share of Rs.10/- each, subject to approval of the Shareholders at the ensuing Annual General Meeting, shall be paid on and from July 24, 2017. Annual General Meeting On Tuesday, July 18, 2017
We hereby inform you that Seventy-Third Annual General Meeting of the Company is scheduled to be held on Tuesday, July 18, 2017 at RAMA AND SUNDRI WATUMULL AUDITORIUM, K C College, 124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani Chowk, Churchgate, Mumbai 400 020 at 3.30 pm. Audited Financial Results For The Fourth Quarter And Year Ended March 31, 2017 (Standalone)
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2017, approved by the Board of Directors at its Meeting held on Friday, May 19, 2017, along with the Auditors Report issued by S R B C & CO. LLP, Statutory Auditors of the Company and Declaration with... Updates
Publication of Board Meeting Notice as per Regulation 47 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in Business Standard (All Edition) and Loksatta on Tuesday, May 9, 2017, in connection with the Meeting of the Board of Directors to be held on Friday, May 19, 2017. Board to consider Final Dividend
Abbott India Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on May 19, 2017, inter alia:1. To consider and approve the text of Audited Financial Results of the Company for the fourth quarter and year ended on March 31, 2017, along with the Audit Report of the Statutory Auditors thereon as required under Regulation 33 of the said Regulations.... Board Meeting On May 19, 2017
Pursuant to Regulation 29 (1) (a) and (e) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 19, 2017 interalia, for the following: 1.To consider and approve the text of Audited Financial Results of the Company for the fourth quarter and year ended on March 31, 2017, along with the Audit Report... NPPA denies request for stent withdrawal by Abbott, India Medtronic
The National Pharmaceutical Pricing Authority (NPPA) on Wednesday denied the request for withdrawal of medical devices by Abbott Healthcare and India Medtronic. In an official statement, NPPA... Price control fall out : Abbott withdraws two stents from Indian market
A little over four years after Abbott introduced its bio-absorbable cardiac stent in India, the healthcare major has decided to pull the product out of India along with another stent Alpine.... Shareholding for the Period Ended March 31, 2017
Abbott India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here